Skip to main navigation
About
Company Overview
History
Management
Board of Directors
Audit Committee
Corporate Responsibility
Social Responsibility
Sustainable Environment
Corporate Philanthropy
Codes of Ethics
Pipeline
Overview
Pain Management
TLC599
TLC590
Ophthalmology
TLC399
Oncology
TLC178
Infectious Diseases
Ampholipad™
ISPM19
Technology
Sustained Release
BioSeizer™
Targeted Delivery
NanoX™
Antibody-Linked Nanomedicines
Other Technologies
Polymeric Micelle
Investors
Corporate Info
Company Profile
Management
IR Contact
News & Events
Press Releases
Events & Presentations
Filings
Pressroom
Press Releases
Media Library
Publications
Careers
Benefits
Job Opportunities
Contact Us
Contact Us
Language
English
繁體中文
日本語
Home
Investors
Corporate information
IR Contacts
Investors
Corporate Information
Company Profile
Management
IR Contact
IR Contact
IR Contact
TLC
Dawn Chi
Corporate Communications
Phone: +886 (0)2 2655 7377
E-mail:
ir@tlcbio.com
Website Notice Block
RSS Feeds
IR Contacts
Print Page
About
Company Overview
History
Management
Board of Directors
Audit Committee
Corporate Responsibility
Pipeline
Overview
Pain Management
Ophthalmology
Oncology
Infectious Diseases
Technology
Sustained Release
Targeted Delivery
Other Technologies
Investors
Corporate Info
News & Events
Filings
Pressroom
Press Releases
Media Library
Publications
Careers
Benefits
Job Opportunities
Contact Us
E-mail Alerts
